We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00424840
Recruitment Status : Completed
First Posted : January 22, 2007
Last Update Posted : November 19, 2014
Sponsor:
Collaborators:
Millennium Pharmaceuticals, Inc.
Genentech, Inc.
Information provided by (Responsible Party):
William Walsh, University of Massachusetts, Worcester

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : March 2014
  Study Completion Date : March 2014

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 17, 2016 July 29, 2016
2 October 7, 2016 November 30, 2016
3 February 22, 2017 April 7, 2017